NCT06639997View on ClinicalTrials.gov

Safety and Tolerability of AZD5148 in Japanese Participants

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

January 19, 2026

Study Completion Date

January 19, 2026

Conditions

Clostridioides Difficile Infection

Interventions

DRUG

AZD5148

Participants will receive AZD5148 as IM injection or IV bolus

DRUG

Placebo

Participants will receive matching doses of placebo as an IM injection or IV bolus

Trial Locations (1)

130-0004

Research Site, Sumida-ku

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY